is semaglutide compound fda approved Compounded not the same as FDA-approved. The has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before FDA says 'no clinical need'
Description
Berberine should not be given to newborns or infants due to the risk of kernicterus
Some people feel appetite suppression within a few weeks, but significant weight reduction takes time
Rate of weight loss may slow down initially during beginning stages of transition, but generally will begin to accelerate with consistent use
Therefore, administration of this drug causes gastrointestinal side effects such as nausea or weight loss
A history of pancreatitis Pancreatitis (inflammation of the pancreas) has been reported in people on GLP-1 medications, though its uncommon and the absolute risk increase is small
